Metastatic Breast Carcinoma — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for metastatic breast carcinoma. 134 active patents protecting 3 drugs from 3+ originators. First major cliff: 2030. Daily refresh.

3
Approved drugs
134
Active US patents
48/100
Avg vulnerability
—
Annual revenue covered

Originators in Metastatic Breast Carcinoma

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Pfizer 101 patents Sanofi 18 patents Accord Hlthcare 15 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating metastatic breast carcinoma. Each bar = one year. Y-axis scaled to peak year (77 patents).

11
28
1
29
7
30
3
31
77
32
21
33
4
34
6
36
2
37
1
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Estrace
ESTRADIOL
 Pfizer 101 37 — 2028-07-10
Taxotere
Docetaxel
 Sanofi 18 59 — 2031-08-07
Gemzar
Gemcitabine Hydrochloride
 Accord Hlthcare 15 48 — 2030-06-28

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12090134 Taxotere method of use 75 2036-05-16
11419842 Taxotere method of use 75 2036-05-16
10842770 Taxotere method of use 68 2031-08-07
10842770 Taxotere method of use 68 2031-08-07
10842770 Taxotere method of use 68 2031-08-07
9763880 Taxotere method of use 62 2033-09-30
9763880 Taxotere method of use 62 2033-09-30
8940786 Taxotere method of use 62 2033-09-30
9763880 Taxotere method of use 62 2033-09-30
8940786 Taxotere method of use 62 2033-09-30

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11795178 Estrace composition of matter 0 2033-09-27
12325714 Estrace composition of matter 0 2033-09-27
11865179 Estrace composition of matter 0 2032-11-21
11865179 Estrace composition of matter 0 2032-11-21
8231906 Estrace composition of matter 0 2030-07-04
8231906 Estrace composition of matter 0 2030-07-04
8231906 Estrace composition of matter 0 2030-07-04
8231906 Estrace composition of matter 0 2030-07-04
8231906 Estrace composition of matter 0 2030-07-04
7300935 Estrace composition of matter 0 2029-01-28

Related